Last Updated : May 9, 2013
Details
FilesGeneric Name:
Lurasidone
Project Status:
Complete
Therapeutic Area:
Schizophrenia
Manufacturer:
Sunovion Pharmaceuticals Inc.
Call for patient/clinician input open:
Brand Name:
Latuda
Project Line:
Reimbursement Review
Project Number:
SR0331-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Submission Type:
Resubmission
Indications:
Schizophrenia
Recommendation Type:
List with criteria/condition
Final Recommendation:
Files
Last Updated : May 9, 2013